Science ❯Research ❯Preclinical Studies

Mouse Models

Human Studies Therapeutic Strategies

FDA Clears MT-125 for First Human Trials in Treatment-Resistant Glioblastoma

It has been licensed to Myosin Therapeutics, which plans to begin human studies within the year.

Study Reveals Aging Stem Cells Drive Midlife Belly Fat Expansion